Skip to content

SPROTECH

Active Public limited companyfounded 1986active for 40 yearsTransportlaan 9, 3600 GenkKBO/BCE: BE 0428.819.182

Lifetime

20 annual accounts with figures on one time axis, 39 filings since 1987
peak of €623,932 in 2016
€186,011▼ 7.0%
lowest -€2.7m in 2025
-€2.7m▼ €4.7m
peak of €3.0m in 2024
€283,338▼ 90.6%
€3.1m▲ 1.9%
peak of 3.8 FTE in 2016
2 FTEunchanged
Board2 names since 2019
2 directors and 1 other
Documentsfilings and deeds
25-08-202625 days late
2025abbreviated format
Loss of €2.7m2 directors reappointed 31-122 directors appointed, 2 resignations 04-08Equity from €3.0m to €283,338Cash from €32,369 to €154,089

Key points

from the 2025 annual accounts

Equity

€283,338 from €3.0m in 2024

Equity fell by 91% in 1 year.

Turnover

≈ €1.0m estimated

The accounts state no turnover.

Debts

€3.1m 92% of the balance sheet
Financial debts 79%Suppliers 1%Other 20%

Of this, €649,968 falls due within a year.

Filings

39 annual accounts since 1987
AprilJune31 JulyOctober1990200020102020

Eight of the last ten came late. The 2019 accounts came in latest, 102 days after the end of the period.

Position in the sector

-€2.7m

Lower net result than 95% of companies in wholesale trade. The sector median is €38,094, over 10,778 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 541 companies had the same profile as SPROTECH has now. Each dot stands for 2 companies, two years later.

85.6%
were still trading
8.5%
stopped another way
5.2%
went bankrupt
  • Micro
  • 20 years or older
  • solvency under 10%
  • a loss of 10% of the balance sheet or more

Another 0.7% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 541 companies, not a prediction for SPROTECH. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, , since 25-06-2025
Director, , since 25-06-2025

Shares in 1 company,

Board & ownership

Recent changes

Registered office moved to Genk The registered office moved to Transportlaan 9, 3600 Genk · Board meeting of 27-10-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0428819182
2 directors reappointed and · and act as permanent representatives · “Daarnaast kan de vennootschap activiteiten uitoefenen op het vlak van interieur en inrichting, waaronder het…” (deed in Dutch) · General meeting of 18-12-2025 · Gazette deed
2 directors appointed, 2 resignations and resign · and appointed · and act as permanent representatives · General meeting of 25-06-2025 · Gazette deed
All 59 events

Comparable companies

same main activity, similar in size and age
Company
SPROTECH Genk €3.4m €186,011 8.4% 2
DAXANT Brussels €2.0m €157,486 35.9% 2
LABAB Charleroi €1.3m €121,083 70.8% 2
ICU MEDICAL BELGIUM Leuven €1.9m €457,175 72.2% 3
bonyf Knokke-Heist €3.4m €55,432 76.8% 1
GRAFIMEDICS Nazareth-De Pinte €1.6m €370,220 24.3% 2.3
EUROMEDIX POINT OF CARE Leuven €3.2m €472,051 3.6% 2.1

These companies have the same main activity as SPROTECH: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €1.3m and €3.4m, founded between 1981 and 2000.

Official details

Source: KBO
Status
Active since 21-03-1986Normal situation
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460and 2 others
Joint committee
340Orthopaedic technologies · annual accounts 2025
Establishment unit
2.037.303.4703600 Genk, since 28-10-1992
Financial year end
31 December
Peppol
Reachable since 16-01-2026
Company details

Annual accounts 2025

€3.4m▼ 44.2%
Employeeson 31-12-2025
2=
Filing
Filed on 25-08-2026
Financials

Insights on SPROTECH

SPROTECH files the abbreviated format. That format states no turnover. The gross margin fell from €192,792 in 2006 to €186,011 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about SPROTECH

What is the company number of SPROTECH?
The company number of SPROTECH is 0428.819.182. The VAT number is the same number with BE in front: BE 0428.819.182.
Where is SPROTECH based?
The registered office is at Transportlaan 9, 3600 Genk.Company details
What does SPROTECH do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of SPROTECH?
SPROTECH is a public limited company (NV).
When was SPROTECH founded?
SPROTECH was founded on 21-03-1986.
Is SPROTECH still active?
Yes, SPROTECH is an active enterprise in the KBO register.
How many employees does SPROTECH have?
SPROTECH had an average of 2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does SPROTECH fall under?
In its 2025 annual accounts, SPROTECH states joint committee 340 (Orthopaedic technologies).
What is the turnover of SPROTECH?
The turnover in financial year 2025 is about €1.0m. This figure is estimated from the gross margin of €186,011 and 85 comparable companies (NACE 46). It probably lies between €440,000 and €1.8m.
Is SPROTECH profitable?
In financial year 2025, SPROTECH made a loss of €2.7m.
Where can I find the annual accounts of SPROTECH?
SPROTECH filed 39 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of SPROTECH due?
SPROTECH must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.